Portfolio Companies

Lund, Sweden, 11.00 CET, Dec 17, 2020 BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, will be moved to the Mid Cap segment on Nasdaq Stock...
Read more

SAN FRANCISCO--(BUSINESS WIRE)--Dec. 17, 2020-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel th...
Read more

Gothenburg, December 15, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for serious lung disorders, today annou...
Read more

Phase 1 Single-Dose Data Show Uptake Across Multiple Tumor Types; No Dose Limiting Toxicities or Treatment-Related Serious Adverse Events HAMILTON, ON and BOSTON, Dec. 10...
Read more

First publication based on Phase III data to document sustained and clinically meaningful bilateral improvement in visual acuity from unilateral injection of a gene therapy ...
Read more

STOCKHOLM — December 9, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-...
Read more

2020-12-08 Oral C21 treatment demonstrates significant clinical improvement on top of corticosteroids Gothenburg, December 08, 2020 – Vicore Pharma Holding AB (publ), a phar...
Read more

STOCKHOLM — December 7, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-...
Read more

The agreement covers 29 countries in Europe Orexo will receive double-digit royalties on future net sales First launches are expected in H2, 2021 Uppsala, Sweden – D...
Read more

STOCKHOLM — December 6, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-t...
Read more